ecropolis

Severe Infection and Risk of Cardiovascular Disease | Risk Factors Associated With Post−COVID-19 Condition | Maternal third dose of BNT162b2 mRNA vaccine and risk of infant COVID-19 hospitalization | Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition |
Antibiotics don’t reduce risk of death from viral respiratory infections |
ABO blood types and SARS-CoV-2 infection assessed using seroprevalence data in a large population-based sample: the SAPRIS-SERO multi-cohort study |
Mechanically Ventilated Patients With Coronavirus Disease 2019 Had a Higher Chance of In-Hospital Death If Treated With High-Flow Nasal Cannula Oxygen Before Intubation

Prior COVID-19 infection associated with increased risk of newly diagnosed erectile dysfunction | A novel tool to eradicate an ancient scourge: the novel oral polio vaccine type 2 story | Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households | Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system |
Projected COVID-19 Mortality Reduction From Paxlovid Rollout |
SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity | Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis | Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers

Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea | Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19 | Clearance of longstanding, immune-deficiency-associated, vaccine-derived polio virus infection following remdesivir therapy for chronic SARS-CoV-2 infection | Outpatient Treatment of COVID-19 and the Development of Long COVID Over 10 Months |
Nirmatrelvir and the Risk of Post-Acute Sequelae of COVID-19 |
Optimal Duration of Systemic Corticosteroids in COVID-19 Treatment | SARS-CoV-2 Exposure in Norway Rats (Rattus norvegicus) from New York City | Exhaled Breath Aerosol Shedding of Highly Transmissible Versus Prior Severe Acute Respiratory Syndrome Coronavirus 2 Variants

Community-onset bacterial coinfection in children critically ill with SARS-CoV-2 infection |
Risk of Coronavirus Disease 2019–Associated Pulmonary Aspergillosis Based on Corticosteroid Duration |
Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection | Long-term gastrointestinal outcomes of COVID-19 | Confronting the evolution and expansion of anti-vaccine activism in the USA |
Effectiveness of Maternal Influenza Vaccination in Peru PRIME Cohort |
Bivalent booster effectiveness against severe COVID-19 outcomes in Finland | Immunomodulators for severe coronavirus disease-2019 in transplant patients | Characteristics and predictors of persistent symptoms post-COVID-19 in children and young people | Parental Nonadherence to Health Policy Recommendations for Prevention of COVID-19 | Viral kinetics of sequential SARS-CoV-2 infections |
Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population | One-Year Adverse Outcomes Among US Adults With Post–COVID-19 Condition

Fatal Fulminant Cerebral Edema in Six Children With SARS-CoV-2 Omicron BA.2 Infection in Taiwan |
Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus in Infants and Children |
COVID-19 vaccines versus pediatric hospitalization | Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 | Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children |
Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid | Effect of covid-19 vaccination on long covid: systematic review |
FDA Authorizes First Over-the-Counter At-Home Test to Detect Both Influenza and COVID-19 Viruses |
Epidemiologic Characteristics of SARS-CoV-2 Recombinant Variant XBB.1.5 | Certifying Deaths Due to Coronavirus Disease 2019

Sex differences in cardiovascular complications and mortality in hospital patients with covid-19 |
Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults | A third vaccine dose equalizes the levels of effectiveness | Sotrovimab retains activity against SARS-CoV-2 Omicron variant | Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients | Viral burden rebound in hospitalized patients with COVID-19 receiving oral antivirals | Serological response to vaccination in post-acute sequelae of COVID | Association of COVID-19 Vaccination With Risk for Incident Diabetes After COVID-19 Infection | Past SARS-CoV-2 infection protection against re-infection | Postacute Sequelae of SARS-CoV-2 in University Setting